Afya (NASDAQ:AFYA) Upgraded at UBS Group

UBS Group upgraded shares of Afya (NASDAQ:AFYA) from a neutral rating to a buy rating in a report released on Monday morning, Marketbeat reports. The brokerage currently has $19.00 price objective on the stock, down from their prior price objective of $19.50.

AFYA has been the topic of a number of other reports. Zacks Research raised shares of Afya to a “hold” rating in a report on Friday, August 8th. Wall Street Zen raised shares of Afya from a “hold” rating to a “buy” rating in a report on Friday, August 22nd. Citigroup raised shares of Afya from a “sell” rating to a “neutral” rating and lowered their price target for the stock from $16.00 to $14.00 in a report on Tuesday, July 29th. Finally, Morgan Stanley set a $17.50 price target on shares of Afya and gave the stock an “overweight” rating in a report on Wednesday, August 6th. Three research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Afya currently has an average rating of “Hold” and a consensus price target of $18.20.

Afya Price Performance

NASDAQ AFYA opened at $15.19 on Monday. The company has a market cap of $1.42 billion, a PE ratio of 11.51, a price-to-earnings-growth ratio of 0.55 and a beta of 0.56. Afya has a 52 week low of $13.47 and a 52 week high of $19.90. The company has a quick ratio of 0.94, a current ratio of 0.94 and a debt-to-equity ratio of 0.22. The firm’s 50-day simple moving average is $15.14 and its two-hundred day simple moving average is $17.00.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of AFYA. Carrera Capital Advisors bought a new position in Afya during the second quarter valued at approximately $1,750,000. Wellington Management Group LLP bought a new position in Afya during the fourth quarter valued at approximately $829,000. Jump Financial LLC bought a new position in Afya during the second quarter valued at approximately $731,000. Lazard Asset Management LLC grew its position in Afya by 54.3% during the fourth quarter. Lazard Asset Management LLC now owns 97,313 shares of the company’s stock valued at $1,545,000 after acquiring an additional 34,246 shares during the last quarter. Finally, Goldman Sachs Group Inc. grew its position in Afya by 167.3% during the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock valued at $809,000 after acquiring an additional 28,226 shares during the last quarter. 88.02% of the stock is currently owned by institutional investors.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.